UK markets close in 6 hours 38 minutes

Novartis AG (NOVN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
88.81+0.71 (+0.81%)
As of 10:37AM CEST. Market open.
Currency in CHF

Valuation measures4

Market cap (intra-day) 179.76B
Enterprise value 195.70B
Trailing P/E 22.12
Forward P/E 13.46
PEG ratio (5-yr expected) 4.64
Price/sales (ttm)4.23
Price/book (mrq)5.01
Enterprise value/revenue 4.10
Enterprise value/EBITDA 10.68

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-0.54%
S&P500 52-week change 324.49%
52-week high 394.52
52-week low 379.21
50-day moving average 387.53
200-day moving average 387.08

Share statistics

Avg vol (3-month) 33.23M
Avg vol (10-day) 33.63M
Shares outstanding 52.04B
Implied shares outstanding 62.04B
Float 81.95B
% held by insiders 14.12%
% held by institutions 139.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43.3
Forward annual dividend yield 43.75%
Trailing annual dividend rate 33.92
Trailing annual dividend yield 34.45%
5-year average dividend yield 43.64
Payout ratio 485.32%
Dividend date 311 Mar 2024
Ex-dividend date 407 Mar 2024
Last split factor 26:5
Last split date 304 Oct 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 31.94%
Operating margin (ttm)30.78%

Management effectiveness

Return on assets (ttm)8.65%
Return on equity (ttm)19.83%

Income statement

Revenue (ttm)47.73B
Revenue per share (ttm)23.17
Quarterly revenue growth (yoy)9.70%
Gross profit (ttm)N/A
EBITDA 18.94B
Net income avi to common (ttm)9.11B
Diluted EPS (ttm)3.98
Quarterly earnings growth (yoy)17.20%

Balance sheet

Total cash (mrq)9.7B
Total cash per share (mrq)4.76
Total debt (mrq)27.28B
Total debt/equity (mrq)68.63%
Current ratio (mrq)0.90
Book value per share (mrq)19.44

Cash flow statement

Operating cash flow (ttm)13.77B
Levered free cash flow (ttm)13.39B